July 26th, 2022 | 🕒
iSpeech.org HELSINKI, July 26, 2022 /PRNewswire/ -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and
July 26th, 2022 | 🕒
iSpeech Finnish immunotherapy company Valo Therapeutics Oy (ValoTx) has obtained exclusive licensing of intellectual property rights (IPR) from the University
January 6th, 2022 | 🕒
Text to Speech Voices HELSINKI, Jan. 6, 2022 /PRNewswire/ -- Valo Therapeutics Oy (Valo Tx), the developer of novel, adaptable immunotherapy
March 1st, 2021 | 🕒
iSpeech BOSTON, March 1, 2021 /PRNewswire/ -- Valo Health LLC (Valo), the technology company working to transform the drug discovery and
Gloss